Jaxwest7: Drug study: Effect of a novel compound (rosiglitazone) on diabetes in BKS.Cg-Dock7m +/+ Leprdb/J female mice (2009)

Jackson Laboratory   With: Yang Y

Jaxwest7 downloads
Click on "Download" link or button below, to see the available downloads for this project.
Institutional authorship Jackson Laboratory     Lab web site
Participants Yang Y
ContactYan Yang     yan.yang@jax.org     Lab web site
AffiliationJAX In Vivo Services
Project type One-strain study
MPD identifiersJaxwest7     MPD:307
Data changelog No updates/corrections.       Initial release date: 06/2009.
Formatted citation
Click above to copy-paste the entire citation for this MPD web page.

Purpose: The goal of the study was to test the efficacy of novel compounds (rosiglitazone) in a diabetic mouse model BKS.Cg-Dock7m +/+ Leprdb/J strain fed glucose.

By posting this data, JAX® In Vivo Services contributes to community research resources and fulfills an agreement with clients to make normative data public.

Investigator's notes and website:

Compound evaluation services: Obesity and type 2 diabetes

Available download:  


Data: Jaxwest7.xls